Loews Corp’s Pediatrix Medical MD Stock Holding History

Loews Corp’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,291	Closed	-$247K	–	156
2018 Q3	$247K	Buy	+5,291	New	+$243K	﹤0.01%	120
2018 Q2	–	Sell	-3,899	Closed	-$217K	–	151
2018 Q1	$217K	Buy	+3,899	New	+$214K	﹤0.01%	133

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loews Corp's MD Position: Q4 2018 in Review

Loews Corp sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 5,291 shares — an estimated $247K sold.

Loews Corp first reported a position in MD in Q1 2018 and held it in 2 quarters. The position peaked at $247K in Q3 2018. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

Loews Corp reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
Loews Corp sold 5,291 Pediatrix Medical shares in Q4 2018, an estimated $247K.
Loews Corp first reported a position in Pediatrix Medical in Q1 2018 and held it in 2 quarters.
Loews Corp's Pediatrix Medical position peaked at $247K in Q3 2018.
307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on Loews Corp's 13F filing for Q4 2018, filed 12 Feb 2019.